![]() |
市场调查报告书
商品编码
1746617
日本週边血管设备市场报告(按设备类型、最终用户和地区)2025-2033Japan Peripheral Vascular Devices Market Report by Device Type, End User, and Region 2025-2033 |
2024年,日本週边血管器械市场规模达5.481亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到10.162亿美元,2025-2033年期间的复合年增长率(CAGR)为6.6%。微创手术因其住院时间短、恢復速度快等特点,其应用日益广泛,成为推动市场成长的主要动力。
週边血管疾病 (PVD) 是一种由心臟和脑外血管收缩、阻塞或痉挛引起的循环系统疾病。这些疾病会导致血管内血流减少,进而引发虚弱、不适、坏疽、腿部脱髮、麻木和肌肉疲劳等症状。为了治疗动脉阻塞和狭窄,医护人员会使用周边血管装置,包括血管成形术导管、週边导丝、腔静脉滤器、支架移植物和栓塞保护装置 (EPD)。週边血管阻塞主要是由斑块堆积引起的,斑块会收缩血管,阻碍血液流向身体各部位。週边血管装置是一种安全的解决方案,可最大限度地降低感染和刺激的风险,同时增强血流并透过动脉输送富氧血液。
日本週边血管疾病市场正呈现良好发展轨迹,这主要得益于全球静脉注射疾病(包括慢性静脉功能不全 (CVI))的盛行率不断上升。週边血管装置在确保脑部、腿部和足部等关键部位获得充足血流,从而维持最佳身体机能方面发挥关键作用。日本老化人口的不断增长以及週边动脉疾病 (PAD) 和动脉阻塞等各种疾病发病率的激增,是导致这一上升趋势的原因之一。吸烟、过量饮酒、缺乏运动和不健康的饮食等生活方式因素在这些健康问题中扮演着重要角色。微创手术 (MIS) 因其併发症少、术后不适感减轻、住院时间短和恢復时间快等优势,日益受到青睐,进一步提振了市场。此外,由于动脉粥状硬化、肥胖症和生活型态相关疾病的盛行率不断上升,动脉粥状硬化切除设备的普及率也不断上升。日本的医疗保健产业正经历大幅成长,消费者的消费能力不断增强,研发投入也不断增加。这些因素共同造就了日本週边血管疾病市场的乐观前景,确保其在预测期内持续成长和发展。
市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外,报告还提供了所有主要公司的详细资料。
Japan peripheral vascular devices market size reached USD 548.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,016.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.6% during 2025-2033. The growing usage of minimally invasive surgeries, as they require shortened hospital stay and have faster recovery, is primarily driving the market growth.
Peripheral vascular disease (PVD) is a circulatory ailment resulting from the constriction, obstruction, or spasms in blood vessels situated outside the heart and brain. These occurrences lead to a diminished blood flow within these vessels, resulting in symptoms like weakness, discomfort, gangrene, leg hair loss, numbness, and muscle fatigue. To address artery blockages and narrowing, healthcare professionals utilize peripheral vascular devices, including angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD). Blockages in the peripheral vasculature, in particular, are primarily caused by the accumulation of plaque, which constricts the blood vessels and hampers blood circulation to various body regions. Peripheral vascular devices are a secure solution that minimizes the risk of infection and irritation while enhancing blood flow and supplying oxygen-rich blood through the arteries.
The Japan peripheral vascular disease market is experiencing a promising trajectory, primarily due to the escalating prevalence of venous diseases, including chronic venous insufficiency (CVI) on a global scale. Peripheral vascular devices play a pivotal role in ensuring adequate blood flow to critical regions like the brain, legs, and feet, thus enabling optimal bodily functions. Contributing to this upward trend is the growing aging population in Japan and the surging incidence of various conditions such as peripheral artery disease (PAD) and arterial blockages. Lifestyle factors, including smoking, excessive alcohol consumption, physical inactivity, and unhealthy dietary choices, have played a significant role in these health issues. The market is further bolstered by the increasing preference for minimally invasive surgeries (MIS), driven by their advantages such as reduced complications, decreased postoperative discomfort, shorter hospital stays, and quicker recovery times. Additionally, the widespread adoption of atherectomy devices is on the rise due to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders. The healthcare sector in Japan is witnessing substantial growth, with consumers having greater spending capacity and increased investment in research and development (R&D) activities. These factors collectively contribute to a positive outlook for the Japan peripheral vascular disease market, ensuring its continued growth and development, over the forecasted period.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.